Deborah Dunsire Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Deborah Dunsire.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Deborah Dunsire. Deborah Dunsire is a Director in ALLERGAN INC ($AGN) and a Director in ALEXION PHARMACEUTICALS INC ($ALXN) and a President and CEO in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and a President, CEO in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and a Director in Ultragenyx Pharmaceutical Inc. ($RARE).
Address: MILLENNIUM PHARMACEUTICALS, INC. 40 LANDSDOWNE STREET CAMBRIDGE 02139 MA
Companies in which Deborah Dunsire is an Insider
ALEXION PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Deborah Dunsire: Director
Holdings: 11,193 shares
Current Value: $1,429,570
Latest Transaction: May 18 2020
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALLERGAN INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Deborah Dunsire: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 19 2015
$AGN Market Capitalization: $90.46B
$AGN Previous Close: $232.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MILLENNIUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Deborah Dunsire: President, CEO, President and CEO
Holdings: 0 shares
Latest Transaction: May 15 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ultragenyx Pharmaceutical Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Deborah Dunsire: Director
Holdings: 10,425 shares
Current Value: $760,087
Latest Transaction: Jun 30 2020
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Deborah Dunsire
Sentiment: All, ALXN, AGN, MLNM, RARE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 | |
| Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 2,550 | 0 | 10,425 | 7.9 K to 10.4 K (+32.38 %) |
| May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 941 | 0 | 12,134 | 11.2 K to 12.1 K (+8.41 %) |
| May 18 2020 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 3,468 | 0 | 11,193 | 7.7 K to 11.2 K (+44.89 %) |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
| Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Dunsire Deborah | Director | Grant | A | 0.00 | 3,000 | 0 | 7,875 | 4.9 K to 7.9 K (+61.54 %) |
| May 17 2019 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 740 | 0 | 7,725 | 7 K to 7.7 K (+10.59 %) |